{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:21:25Z","timestamp":1794558085046,"version":"4.9.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100017530","name":"Fresenius Kabi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To assess the ability of dual-energy X-ray absorptiometry (DXA) and hand-grip dynamometer to measure damage in inflammatory myopathies (IM).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Forty adult IM patients with a disease duration \u226512\u2009months, low or no disease activity for \u22656\u2009months, were prospectively enrolled. Thirty healthy age and sex-matched volunteers were enrolled as controls. Whole-body DXA and hand-grip dynamometer were used to measure muscle mass, grip strength and diagnose sarcopenia (EWGSOP2 criteria). Relationships between the results of strength in 12 muscles, functional tests, patient-reported disability, IMACS damage score, and history of the disease were assessed. The serum levels of potential molecular actors in the damage were measured.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>DXA and grip strength measurements took \u226420\u2009min. Both muscle mass and grip strength were decreased in IM patients vs volunteers (\u221210% and \u221230%, respectively) with a dispersion that varied widely (interquartile range \u221224.3% to +7.8% and \u221251.3% to \u221218.9%, respectively). Muscle mass and grip strength were non-redundantly correlated (r up to 0.6, P\u2009=\u20090.0001) with strength in 14 muscles (manual muscle test and hand-held dynamometer), functions (of limbs, respiratory and deglutition muscles), patient-reported disability, damage (extension and severity in muscular and extra-muscular domains) and blood levels of several myokines. Seven IM patients (17.5%) were sarcopenic. They had the worst damage, impaired functions, disability and history of severe myopathy. Decreased irisin and osteonectin levels were associated with sarcopenia (area under the curve 0.71 and 0.80, respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>DXA and hand-grip dynamometer are useful tools to assess damage in IM. Irisin and osteonectin may play a role in IM damage pathogenesis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae207","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T04:57:55Z","timestamp":1711601875000},"page":"2503-2514","source":"Crossref","is-referenced-by-count":15,"title":["Sarcopenia assessed by DXA and hand-grip dynamometer: a potential marker of damage, disability and myokines imbalance in inflammatory myopathies"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4834-5804","authenticated-orcid":false,"given":"Margherita","family":"Giannini","sequence":"first","affiliation":[{"name":"Physiologie et explorations fonctionnelles musculaires, University Hospital of Strasbourg , Strasbourg, France"},{"name":"UR3072 \u2018mitochondrie, stress oxydant et protection musculaire\u2019, Centre de Recherche en Biom\u00e9decine, University of Strasbourg , Strasbourg, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Auto-immunes Syst\u00e9miques Rares, University Hospital of Strasbourg , Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Charles","sequence":"additional","affiliation":[{"name":"UR3072 \u2018mitochondrie, stress oxydant et protection musculaire\u2019, Centre de Recherche en Biom\u00e9decine, University of Strasbourg , Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Evrard","sequence":"additional","affiliation":[{"name":"Physiologie et explorations fonctionnelles, University Hospital of Strasbourg , Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Blaess","sequence":"additional","affiliation":[{"name":"Physiologie et explorations fonctionnelles musculaires, University Hospital of Strasbourg , Strasbourg, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Auto-immunes Syst\u00e9miques Rares, University Hospital of Strasbourg , Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maude","family":"Bouchard-Marmen","sequence":"additional","affiliation":[{"name":"Service de Rhumatologie, University Hospital of Qu\u00e9bec, University Laval , Quebec City, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Debrut","sequence":"additional","affiliation":[{"name":"UR3072 \u2018mitochondrie, stress oxydant et protection musculaire\u2019, Centre de Recherche en Biom\u00e9decine, University of Strasbourg , Strasbourg, France"},{"name":"Institut de G\u00e9n\u00e9tique et de Biologie Mol\u00e9culaire et Cellulaire (IGBMC), University of Strasbourg, INSERM U1258, CNRS UMR 7104 , Illkirch, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6918-4731","authenticated-orcid":false,"given":"Simone","family":"Perniola","sequence":"additional","affiliation":[{"name":"Clinical Immunology Unit, Fondazione Policlinico Universitario A. Gemelli-IRCCS , Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Laverny","sequence":"additional","affiliation":[{"name":"Institut de G\u00e9n\u00e9tique et de Biologie Mol\u00e9culaire et Cellulaire (IGBMC), University of Strasbourg, INSERM U1258, CNRS UMR 7104 , Illkirch, France"},{"name":"OSCAR, French Network for Rare Bone Diseases , Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose-Marie","family":"Javier","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence des Maladies Auto-immunes Syst\u00e9miques Rares, University Hospital of Strasbourg , Strasbourg, France"},{"name":"Service de Rhumatologie, University hospital of Strasbourg , Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2885-8757","authenticated-orcid":false,"given":"Anne","family":"Charloux","sequence":"additional","affiliation":[{"name":"UR3072 \u2018mitochondrie, stress oxydant et protection musculaire\u2019, Centre de Recherche en Biom\u00e9decine, University of Strasbourg , Strasbourg, France"},{"name":"Physiologie et explorations fonctionnelles, University Hospital of Strasbourg , Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Geny","sequence":"additional","affiliation":[{"name":"UR3072 \u2018mitochondrie, stress oxydant et protection musculaire\u2019, Centre de Recherche en Biom\u00e9decine, University of Strasbourg , Strasbourg, France"},{"name":"Physiologie et explorations fonctionnelles, University Hospital of Strasbourg , Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Meyer","sequence":"additional","affiliation":[{"name":"Physiologie et explorations fonctionnelles musculaires, University Hospital of Strasbourg , Strasbourg, France"},{"name":"UR3072 \u2018mitochondrie, stress oxydant et protection musculaire\u2019, Centre de Recherche en Biom\u00e9decine, University of Strasbourg , Strasbourg, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Auto-immunes Syst\u00e9miques Rares, University Hospital of Strasbourg , Strasbourg, France"},{"name":"Service de Rhumatologie, University hospital of Strasbourg , Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"2024090404221605800_keae207-B1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jbspin.2017.03.005","article-title":"Inflammatory myopathies: a new landscape","volume":"85","author":"Meyer","year":"2018","journal-title":"Joint Bone Spine"},{"key":"2024090404221605800_keae207-B2","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/acr.22068","article-title":"Improvement in health and possible reduction in disease activity using endurance exercise in patients with established polymyositis and dermatomyositis: a multicenter randomized controlled trial with a 1-year open extension followup: health and disease activity after endurance exercise in PM\/DM","volume":"65","author":"Alemo Munters","year":"2013","journal-title":"Arthritis Care Res"},{"key":"2024090404221605800_keae207-B3","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/rheumatology\/40.11.1262","article-title":"Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies","volume":"40","author":"Miller","year":"2001","journal-title":"Rheumatology"},{"key":"2024090404221605800_keae207-B4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00002281-199611000-00002","article-title":"Assessment of disease activity and its sequelae in children and adults with myositis","volume":"8","author":"Rider","year":"1996","journal-title":"Curr Opin Rheumatol"},{"key":"2024090404221605800_keae207-B5","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/rheumatology\/kep302","article-title":"Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset","volume":"48","author":"Sanner","year":"2009","journal-title":"Rheumatol Oxf Engl"},{"key":"2024090404221605800_keae207-B6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/03009742.2011.608376","article-title":"Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study","volume":"41","author":"Mathiesen","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"2024090404221605800_keae207-B7","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1002\/art.24904","article-title":"Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index","volume":"60","author":"Rider","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2024090404221605800_keae207-B8","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/ard.2005.045690","article-title":"Long-term outcome in polymyositis and dermatomyositis","volume":"65","author":"Bronner","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2024090404221605800_keae207-B9","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/art.22780","article-title":"Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis","volume":"57","author":"Alexanderson","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2024090404221605800_keae207-B10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-59745-403-2_12","volume-title":"Nutrition and rheumatic disease [internet]","author":"Loell","year":"2008"},{"key":"2024090404221605800_keae207-B11","doi-asserted-by":"crossref","first-page":"e000784","DOI":"10.1136\/rmdopen-2018-000784","article-title":"Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected]","volume":"4","author":"Meyer","year":"2018","journal-title":"RMD Open"},{"key":"2024090404221605800_keae207-B12","first-page":"S118","article-title":"Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ)","volume":"63 Suppl 11","author":"Rider","year":"2011","journal-title":"Arthritis Care Res"},{"key":"2024090404221605800_keae207-B13","doi-asserted-by":"crossref","first-page":"e12954","DOI":"10.1111\/bpa.12954","article-title":"MRI and muscle imaging for idiopathic inflammatory myopathies","volume":"31","author":"Malartre","year":"2021","journal-title":"Brain Pathol Zurich Switz"},{"key":"2024090404221605800_keae207-B14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"2024090404221605800_keae207-B15","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00421-010-1795-x","article-title":"Reliability and accuracy of segmental bioelectrical impedance analysis for assessing muscle and fat mass in older Europeans: a comparison with dual-energy X-ray absorptiometry","volume":"111","author":"Mally","year":"2011","journal-title":"Eur J Appl Physiol"},{"key":"2024090404221605800_keae207-B16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.archger.2019.03.005","article-title":"Relationship between grip strength and global muscle strength in community-dwelling older people","volume":"82","author":"Porto","year":"2019","journal-title":"Arch Gerontol Geriatr"},{"key":"2024090404221605800_keae207-B17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41232-016-0022-5","article-title":"Age-related sarcopenia and its pathophysiological bases","volume":"36","author":"Ogawa","year":"2016","journal-title":"Inflamm Regen"},{"key":"2024090404221605800_keae207-B18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fphys.2019.00042","article-title":"Role of myokines in regulating skeletal muscle mass and function","volume":"10","author":"Lee","year":"2019","journal-title":"Front Physiol"},{"key":"2024090404221605800_keae207-B19","doi-asserted-by":"crossref","first-page":"8632","DOI":"10.1038\/s41598-021-87974-6","article-title":"Prediction of sarcopenia using a battery of circulating biomarkers","volume":"11","author":"Qaisar","year":"2021","journal-title":"Sci Rep"},{"key":"2024090404221605800_keae207-B20","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1136\/annrheumdis-2017-212786","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"77","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2024090404221605800_keae207-B21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1468-1331.2010.03012.x","article-title":"EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia","volume":"17","author":"Kyriakides","year":"2010","journal-title":"Eur J Neurol"},{"key":"2024090404221605800_keae207-B22","author":"Ricci","year":"2011"},{"key":"2024090404221605800_keae207-B23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop:: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord NMD"},{"key":"2024090404221605800_keae207-B24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","article-title":"239th ENMC International Workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018","volume":"30","author":"Mammen","year":"2020","journal-title":"Neuromuscul Disord NMD"},{"key":"2024090404221605800_keae207-B25","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"key":"2024090404221605800_keae207-B26","doi-asserted-by":"crossref","first-page":"974078","DOI":"10.3389\/fimmu.2022.974078","article-title":"Scleromyositis: a distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis","volume":"13","author":"Giannini","year":"2022","journal-title":"Front Immunol"},{"key":"2024090404221605800_keae207-B27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","article-title":"International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease","volume":"43","author":"Isenberg","year":"2004","journal-title":"Rheumatology"},{"key":"2024090404221605800_keae207-B28","doi-asserted-by":"crossref","first-page":"2000289","DOI":"10.1183\/13993003.00289-2020","article-title":"Official ERS technical standard: global lung function initiative reference values for static lung volumes in individuals of European ancestry","volume":"57","author":"Hall","year":"2021","journal-title":"Eur Respir J"},{"key":"2024090404221605800_keae207-B29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s40520-016-0626-2","article-title":"Serum markers of inflammation and oxidative stress in sarcopenia","volume":"29","author":"Can","year":"2017","journal-title":"Aging Clin Exp Res"},{"key":"2024090404221605800_keae207-B30","first-page":"69","article-title":"Statistics corner: a guide to appropriate use of correlation coefficient in medical research","volume":"24","author":"Mukaka","year":"2012","journal-title":"Malawi Med J J Med Assoc Malawi"},{"key":"2024090404221605800_keae207-B31","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","article-title":"Sarcopenia","volume":"393","author":"Cruz-Jentoft","year":"2019","journal-title":"Lancet Lond Engl"},{"key":"2024090404221605800_keae207-B32","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1136\/ard.2010.142117","article-title":"Interrater reliability and aspects of validity of the myositis damage index","volume":"70","author":"Sultan","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2024090404221605800_keae207-B33","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/rheumatology\/keq356","article-title":"Patients with polymyositis or dermatomyositis have reduced grip force and health-related quality of life in comparison with reference values: an observational study","volume":"50","author":"Regardt","year":"2011","journal-title":"Rheumatology"},{"key":"2024090404221605800_keae207-B34","first-page":"270","article-title":"Patterns of body composition and alteration after treatment in patients with newly diagnosed idiopathic inflammatory myopathies","volume":"62","author":"Yang"},{"key":"2024090404221605800_keae207-B35","doi-asserted-by":"crossref","first-page":"9130","DOI":"10.3390\/ijerph17239130","article-title":"Prevalence of sarcopenia in community-dwelling older adults in Valencia, Spain","volume":"17","author":"Guillam\u00f3n-Escudero","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"2024090404221605800_keae207-B36","doi-asserted-by":"crossref","first-page":"e002600","DOI":"10.1136\/rmdopen-2022-002600","article-title":"Prevalence of sarcopenia in patients with rheumatoid arthritis using the revised EWGSOP2 and the FNIH definition","volume":"8","author":"Dietzel","year":"2022","journal-title":"RMD Open"},{"key":"2024090404221605800_keae207-B37","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41430-020-00780-7","article-title":"Sarcopenia in hospitalized geriatric patients: insights into prevalence and associated parameters using new EWGSOP2 guidelines","volume":"75","author":"Bertschi","year":"2021","journal-title":"Eur J Clin Nutr"},{"key":"2024090404221605800_keae207-B38","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/ar4263","article-title":"Improved exercise performance and increased aerobic capacity after endurance training of patients with stable polymyositis and dermatomyositis","volume":"15","author":"Alemo Munters","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2024090404221605800_keae207-B39","doi-asserted-by":"crossref","first-page":"155533","DOI":"10.1016\/j.metabol.2023.155533","article-title":"Epidemiology of sarcopenia: prevalence, risk factors, and consequences","volume":"144","author":"Yuan","year":"2023","journal-title":"Metabolism"},{"key":"2024090404221605800_keae207-B40","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.3390\/ijms24032469","article-title":"Elevated expression of ADAM10 in skeletal muscle of patients with idiopathic inflammatory myopathies could be responsible for FNDC5\/Irisin unbalance","volume":"24","author":"Zerlotin","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2024090404221605800_keae207-B41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1369\/jhc.2008.951954","article-title":"Secreted protein acidic and rich in cysteine (SPARC) in human skeletal muscle","volume":"57","author":"J\u00f8rgensen","year":"2009","journal-title":"J Histochem Cytochem Off J Histochem Soc"},{"key":"2024090404221605800_keae207-B42","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/jcb.10645","article-title":"Fibroblast growth factor receptor-1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: a role for protein kinase A","volume":"90","author":"Motamed","year":"2003","journal-title":"J Cell Biochem"},{"key":"2024090404221605800_keae207-B43","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s13105-015-0433-9","article-title":"Irisin, a unique non-inflammatory myokine in stimulating skeletal muscle metabolism","volume":"71","author":"Vaughan","year":"2015","journal-title":"J Physiol Biochem"},{"key":"2024090404221605800_keae207-B44","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1038\/s41598-017-02557-8","article-title":"Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice","volume":"7","author":"Colaianni","year":"2017","journal-title":"Sci Rep"},{"key":"2024090404221605800_keae207-B45","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/mus.23822","article-title":"Loss of SPARC in mouse skeletal muscle causes myofiber atrophy","volume":"48","author":"Nakamura","year":"2013","journal-title":"Muscle Nerve"},{"key":"2024090404221605800_keae207-B46","first-page":"1538","article-title":"Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans","volume":"38","author":"Huh","year":"2014","journal-title":"Int J Obes 2005"},{"key":"2024090404221605800_keae207-B47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.13345","article-title":"Irisin and musculoskeletal health","volume":"1402","author":"Colaianni","year":"2017","journal-title":"Ann N Y Acad Sci"},{"key":"2024090404221605800_keae207-B48","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/gutjnl-2011-300776","article-title":"A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise","volume":"62","author":"Aoi","year":"2013","journal-title":"Gut"},{"key":"2024090404221605800_keae207-B49","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2119\/molmed.2010.00016","article-title":"A longitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis","volume":"16","author":"Nader","year":"2010","journal-title":"Mol Med"},{"key":"2024090404221605800_keae207-B50","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/art.42561","article-title":"Refining incidence and characteristics of inflammatory myopathies: a quadruple-source capture-recapture survey using the 2017 European League Against Rheumatism\/American College of Rheumatology Classification Criteria","volume":"75","author":"Debrut","year":"2023","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae207\/57345972\/keae207.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/9\/2503\/59007306\/keae207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/9\/2503\/59007306\/keae207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T11:25:44Z","timestamp":1725449144000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/9\/2503\/7636484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,3,27]]},"published-print":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae207","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,3,27]]}}}